Pacific Health Financials
This page shows Pacific Health (PFHO) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Pacific Health has an operating margin of 14.1%, meaning the company retains $14 of operating profit per $100 of revenue. This strong profitability earns a score of 70/100, reflecting efficient cost management and pricing power. This is up from 12.0% the prior year.
Pacific Health's revenue grew 7.7% year-over-year to $6.1M, a solid pace of expansion. This earns a growth score of 51/100.
Pacific Health carries a low D/E ratio of 0.06, meaning only $0.06 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 16.54, Pacific Health holds $16.54 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.
Pacific Health has a free cash flow margin of 11.0%, earning a moderate score of 55/100. The company generates positive cash flow after capital investments, but with room for improvement.
Pacific Health's ROE of 7.6% shows moderate profitability relative to equity, earning a score of 30/100. This is up from 7.1% the prior year.
Pacific Health scores 15.46, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($15.4M) relative to total liabilities ($746K). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Pacific Health passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Pacific Health generates $0.76 in operating cash flow ($675K OCF vs $884K net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Pacific Health earns $240.0 in operating income for every $1 of interest expense ($853K vs $4K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Pacific Health generated $6.1M in revenue in fiscal year 2024. This represents an increase of 7.7% from the prior year.
Pacific Health's EBITDA was $887K in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 23.8% from the prior year.
Pacific Health generated $666K in free cash flow in fiscal year 2024, representing cash available after capex. This represents a decrease of 27.2% from the prior year.
Pacific Health reported $884K in net income in fiscal year 2024. This represents an increase of 15.1% from the prior year.
Pacific Health earned $0.07 per diluted share (EPS) in fiscal year 2024. This represents an increase of 16.7% from the prior year.
Pacific Health held $2.1M in cash against $0 in long-term debt as of fiscal year 2024.
Pacific Health had 13M shares outstanding in fiscal year 2024. This represents an increase of 0.0% from the prior year.
Pacific Health's operating margin was 14.1% in fiscal year 2024, reflecting core business profitability. This is up 2.0 percentage points from the prior year.
Pacific Health's net profit margin was 14.6% in fiscal year 2024, showing the share of revenue converted to profit. This is up 0.9 percentage points from the prior year.
Pacific Health's ROE was 7.6% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is up 0.5 percentage points from the prior year.
Pacific Health invested $9K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 47.9% from the prior year.
PFHO Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.6M-8.1% | $1.7M-5.1% | $1.8M+11.9% | $1.6M+8.3% | $1.5M-2.6% | $1.5M+10.2% | $1.4M-11.9% | $1.6M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $186K-18.3% | $228K+49.3% | $153K-25.2% | $204K+11.7% | $183K-9.6% | $202K+39.1% | $145K-36.0% | $227K |
| Operating Income | $205K-32.5% | $304K-3.5% | $314K-5.8% | $334K+120.3% | $152K-21.1% | $192K+9.6% | $175K-42.4% | $304K |
| Interest Expense | $0 | $0-100.0% | $2K-57.2% | $4K | $0 | $0 | $0 | N/A |
| Income Tax | $87K-66.3% | $259K+127.0% | $114K-11.8% | $129K+43.1% | $90K+8.3% | $83K+8.3% | $77K-41.0% | $131K |
| Net Income | $223K-65.0% | $637K+117.6% | $293K-1.0% | $296K+69.1% | $175K-18.9% | $216K+9.2% | $197K-29.8% | $281K |
| EPS (Diluted) | $0.02-60.0% | $0.05+150.0% | $0.020.0% | $0.02+100.0% | $0.01-50.0% | $0.020.0% | $0.02-33.3% | $0.03 |
PFHO Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.3M-0.2% | $13.3M+5.2% | $12.7M+1.8% | $12.4M+2.4% | $12.1M+1.6% | $11.9M-0.8% | $12.0M+2.4% | $11.8M |
| Current Assets | $13.2M0.0% | $13.2M+5.3% | $12.6M+1.8% | $12.3M+2.2% | $12.1M+1.7% | $11.9M-0.4% | $11.9M+3.0% | $11.6M |
| Cash & Equivalents | $2.2M+1.1% | $2.2M-8.5% | $2.4M+13.9% | $2.1M-18.7% | $2.5M-2.8% | $2.6M-7.7% | $2.8M+13.8% | $2.5M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $1.0M-6.8% | $1.1M+17.0% | $933K-9.3% | $1.0M-5.9% | $1.1M+16.2% | $941K+7.1% | $879K-13.9% | $1.0M |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $453K-35.1% | $698K+3.1% | $677K-9.2% | $746K-0.3% | $748K+3.0% | $726K-30.1% | $1.0M+9.5% | $948K |
| Current Liabilities | $453K-35.1% | $698K+3.1% | $677K-9.2% | $746K-0.3% | $748K+3.0% | $726K-29.3% | $1.0M+9.6% | $936K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $12.8M+1.8% | $12.6M+5.3% | $12.0M+2.5% | $11.7M+2.6% | $11.4M+1.6% | $11.2M+2.0% | $11.0M+1.8% | $10.8M |
| Retained Earnings | $12.4M+1.8% | $12.2M+5.5% | $11.6M+2.6% | $11.3M+2.7% | $11.0M+1.6% | $10.8M+2.0% | $10.6M+1.9% | $10.4M |
PFHO Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $24K-94.8% | $455K+37.6% | $331K-41.8% | $568K+1654.5% | -$37K+75.2% | -$147K-150.6% | $291K-41.9% | $501K |
| Capital Expenditures | $907 | $0-100.0% | $9K+409.3% | $2K-0.6% | $2K-17.2% | $2K-45.9% | $4K-72.0% | $13K |
| Free Cash Flow | $23K-95.0% | $455K+41.2% | $322K-43.1% | $566K+1581.7% | -$38K+74.4% | -$149K-152.0% | $287K-41.1% | $488K |
| Investing Cash Flow | -$907+99.9% | -$656K-7608.9% | -$9K+99.1% | -$950K-56428.7% | -$2K+99.1% | -$178K-4653.6% | -$4K+98.7% | -$295K |
| Financing Cash Flow | -$125+80.0% | -$625+98.2% | -$35K0.0% | -$35K0.0% | -$35K-133.3% | $106K | $0+100.0% | -$72K |
| Dividends Paid | $125 | N/A | N/A | $0 | $0+100.0% | -$14K-200.0% | $14K-80.4% | $72K |
| Share Buybacks | $0 | $0 | $0 | N/A | N/A | N/A | N/A | N/A |
PFHO Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | 12.9%-4.7pp | 17.6%+0.3pp | 17.3%-3.3pp | 20.5%+10.4pp | 10.1%-2.4pp | 12.5%-0.1pp | 12.5%-6.6pp | 19.1% |
| Net Margin | 14.1%-22.8pp | 36.9%+20.8pp | 16.1%-2.1pp | 18.2%+6.5pp | 11.7%-2.3pp | 14.0%-0.1pp | 14.1%-3.6pp | 17.7% |
| Return on Equity | 1.7%-3.3pp | 5.1%+2.6pp | 2.4%-0.1pp | 2.5%+1.0pp | 1.5%-0.4pp | 1.9%+0.1pp | 1.8%-0.8pp | 2.6% |
| Return on Assets | 1.7%-3.1pp | 4.8%+2.5pp | 2.3%-0.1pp | 2.4%+0.9pp | 1.4%-0.4pp | 1.8%+0.2pp | 1.6%-0.8pp | 2.4% |
| Current Ratio | 29.17+10.2 | 18.93+0.4 | 18.55+2.0 | 16.54+0.4 | 16.15-0.2 | 16.35+4.7 | 11.60-0.8 | 12.36 |
| Debt-to-Equity | 0.04-0.0 | 0.060.0 | 0.060.0 | 0.060.0 | 0.070.0 | 0.06-0.0 | 0.090.0 | 0.09 |
| FCF Margin | 1.5%-24.9pp | 26.4%+8.6pp | 17.7%-17.1pp | 34.8%+37.4pp | -2.5%+7.1pp | -9.7%-30.2pp | 20.5%-10.2pp | 30.7% |
Similar Companies
Frequently Asked Questions
What is Pacific Health's annual revenue?
Pacific Health (PFHO) reported $6.1M in total revenue for fiscal year 2024. This represents a 7.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Pacific Health's revenue growing?
Pacific Health (PFHO) revenue grew by 7.7% year-over-year, from $5.6M to $6.1M in fiscal year 2024.
Is Pacific Health profitable?
Yes, Pacific Health (PFHO) reported a net income of $884K in fiscal year 2024, with a net profit margin of 14.6%.
What is Pacific Health's earnings per share (EPS)?
Pacific Health (PFHO) reported diluted earnings per share of $0.07 for fiscal year 2024. This represents a 16.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Pacific Health's EBITDA?
Pacific Health (PFHO) had EBITDA of $887K in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
What is Pacific Health's operating margin?
Pacific Health (PFHO) had an operating margin of 14.1% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Pacific Health's net profit margin?
Pacific Health (PFHO) had a net profit margin of 14.6% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Pacific Health's return on equity (ROE)?
Pacific Health (PFHO) has a return on equity of 7.6% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is Pacific Health's free cash flow?
Pacific Health (PFHO) generated $666K in free cash flow during fiscal year 2024. This represents a -27.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Pacific Health's operating cash flow?
Pacific Health (PFHO) generated $675K in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Pacific Health's total assets?
Pacific Health (PFHO) had $12.4M in total assets as of fiscal year 2024, including both current and long-term assets.
What are Pacific Health's capital expenditures?
Pacific Health (PFHO) invested $9K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
How many shares does Pacific Health have outstanding?
Pacific Health (PFHO) had 13M shares outstanding as of fiscal year 2024.
What is Pacific Health's current ratio?
Pacific Health (PFHO) had a current ratio of 16.54 as of fiscal year 2024, which is generally considered healthy.
What is Pacific Health's debt-to-equity ratio?
Pacific Health (PFHO) had a debt-to-equity ratio of 0.06 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Pacific Health's return on assets (ROA)?
Pacific Health (PFHO) had a return on assets of 7.1% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Pacific Health's Altman Z-Score?
Pacific Health (PFHO) has an Altman Z-Score of 15.46, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Pacific Health's Piotroski F-Score?
Pacific Health (PFHO) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Pacific Health's earnings high quality?
Pacific Health (PFHO) has an earnings quality ratio of 0.76x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Pacific Health cover its interest payments?
Pacific Health (PFHO) has an interest coverage ratio of 240.0x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Pacific Health?
Pacific Health (PFHO) scores 68 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.